Application 209777

Type
NDA
Sponsor
INSPIRION DELIVERY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ROXYBONDOXYCODONE HYDROCHLORIDETABLET;ORAL5MGNoNo
002ROXYBONDOXYCODONE HYDROCHLORIDETABLET;ORAL15MGNoNo
003ROXYBONDOXYCODONE HYDROCHLORIDETABLET;ORAL30MGNoNo
004ROXYBONDOXYCODONE HYDROCHLORIDETABLET;ORAL10MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65597-501Roxybondoxycodone hydrochlorideDaiichi Sankyo Inc.NDACurrent
65597-501Roxybondoxycodone hydrochlorideDaiichi Sankyo Inc.NDACurrent
65597-502Roxybondoxycodone hydrochlorideDaiichi Sankyo Inc.NDACurrent
65597-502Roxybondoxycodone hydrochlorideDaiichi Sankyo Inc.NDACurrent
65597-503Roxybondoxycodone hydrochlorideDaiichi Sankyo Inc.NDACurrent
65597-503Roxybondoxycodone hydrochlorideDaiichi Sankyo Inc.NDACurrent
81140-101RoxyBondOxycodone hydrochlorideProtega Pharmaceuticals LLCNDACurrent
81140-102RoxyBondOxycodone hydrochlorideProtega Pharmaceuticals LLCNDACurrent
81140-103RoxyBondOxycodone hydrochlorideProtega Pharmaceuticals LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84641SUPPL 2026-01-05
84583SUPPL 2025-12-29
81508SUPPL 2025-03-11
81503SUPPL 2025-03-11
81502SUPPL 2025-03-10
81501SUPPL 2025-03-10
80085SUPPL 2024-11-04
78221SUPPL 2024-04-23
78191SUPPL 2024-04-19
77081SUPPL 2023-12-19
76986SUPPL 2023-12-19
76041ORIG 2023-11-02
66531SUPPL2021-03-05
66530SUPPL2021-03-05
66529SUPPL2021-03-05
60456SUPPL2019-10-09
60455SUPPL2019-10-09
60356SUPPL2019-10-08
57124SUPPL2019-01-04
57090SUPPL2019-01-02
55708SUPPL2018-10-01
55707SUPPL2018-10-01
55515SUPPL2018-09-19
55514SUPPL2018-09-19
49665ORIG2017-09-05
48087ORIG2017-04-24
48086ORIG2017-04-24
48085ORIG2017-04-24
48084ORIG2017-04-24